Found 28 matching trials
Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease PHASE2 The primary objective of this study is to assess the efficacy of Glycopyrro...
Show More Location
Pearl Investigative Site
Learn More & Join Trial
Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD) PHASE3 To compare the bronchodilator efficacy and safety of tiotropium inhalation ...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE4 The purpose of this study is to further figure out differences of glycopyrr...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1 PHASE4 A randomized, placebo-controlled, double-blind, parallel group, multi cente...
Show More Location
205.477.001039 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease PHASE3 This study assessed the efficacy and safety of indacaterol (150 µg once dai...
Show More Location
Novartis Investigator Site
Learn More & Join Trial
Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device PHASE1 An Open Label Study to Assess the Effect of Patient Use and Robustness of T...
Show More Location
Vanguard Clinical Research, LLC
Learn More & Join Trial
Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease PHASE3 Direct comparison studies of the tiotropium HandiHaler® 18 µg and Respimat®...
Show More Location
205.452.01107 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD PHASE4 This study will evaluate the efficacy and safety of QVA149 (110/50 μg o.d.)...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease PHASE2 GSK573719 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease PHASE2 The purpose of this study is to evaluate the dose-response of different dos...
Show More Location
Chiesi Investigational Site
Learn More & Join Trial